Ecolab Inc. (ECL)
Ecolab (ECL) Earnings Expected to Grow: Should You Buy?
Ecolab (ECL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Ecolab (ECL) Beat Estimates Again in Its Next Earnings Report?
Ecolab (ECL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here is Why Growth Investors Should Buy Ecolab (ECL) Now
Ecolab (ECL) could produce exceptional returns because of its solid growth attributes.
Ecolab (ECL) Upgraded to Buy: Here's What You Should Know
Ecolab (ECL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Why Ecolab (ECL) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Citi's Drew Pettit on opportunities in nuclear energy
Drew Pettit, Citi Research U.S. equity strategist, joins 'The Exchange' to discuss opportunities in nuclear energy, his picks for green stocks, and more
Why Is Ecolab (ECL) Up 8.2% Since Last Earnings Report?
Ecolab (ECL) reported earnings 30 days ago. What's next for the stock?
Reasons to Retain Ecolab (ECL) Stock in Your Portfolio Now
Ecolab's (ECL) focus on cost efficiency programs raises optimism about the stock.
Looking for a Growth Stock? 3 Reasons Why Ecolab (ECL) is a Solid Choice
Ecolab (ECL) possesses solid growth attributes, which could help it handily outperform the market.
Ecolab (ECL) Sells Surgical Solutions Business to Medline
Ecolab's (ECL) deal to sell its global surgical solutions business to Medline enables it to focus on infection prevention and instrument reprocessing while enhancing shareholders' returns.
Ecolab Inc. (ECL) Q2 2024 Earnings Call Transcript
Ecolab Inc. (NYSE:ECL ) Q2 2024 Earnings Conference Call July 30, 2024 1:00 PM ET Company Participants Andy Hedberg - Vice President, Investor Relations Christophe Beck - Chairman & Chief Executive Officer Scott Kirkland - Chief Financial Officer Conference Call Participants Tim Mulrooney - William Blair Ashish Sabadra - RBC Capital Markets Ronan Kennedy - Barclays John Roberts - Mizuho Securities Lucas Beaumont - UBS Chris Parkinson - Wolfe Research John McNulty - BMO Capital Markets Jeff Zekauskas - JPMorgan David Begleiter - Deutsche Bank Pavel Molchanov - Raymond James Shlomo Rosenbaum - Stifel Steve Byrne - Bank of America Kevin McCarthy - Vertical Research Patrick Cunningham - Citi Andy Wittmann - Robert W. Baird Mike Harrison - Seaport Research Vincent Andrews - Morgan Stanley Operator Greetings.
Ecolab (ECL) Q2 Earnings Surpass Estimates, Margins Rise
Ecolab's (ECL) robust performance across the majority of its segments drives its second-quarter sales amid business challenges.
